Thyrogen-stimulated FDG-PET can localize recurrence of thyroid carcinoma but with a relatively low sensitivity if serum thyroglobulin is between 2 and 10 µg/L on T4 suppression.
PET-CT Is Superior Technique for Detecting Extranodal Lymphoma Sites

FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease.
Paes FM, Kalkanis DG, et al: RadioGraphics 2010; 30 (January-February): 269-291 PET/CT is highly accurate for detecting extranodal tumor involvement in initial staging exams.
Background: Detection of extranodal sites of tumor involvement in patients with lymphoma is important for optimal management. Contrast-enhanced CT (ceCT) has a modest level of accuracy for this purpose. Objective: To provide an overview on use of PET/CT for evaluation of extranodal sites of lymphoma (both Hodgkin's [HL] and non-Hodgkin's [NHL]). Discussion: The authors begin by pointing out the most common sites of extranodal involvement including Waldeyer ring, central nervous system (CNS), bone marrow, spleen, and skin. PET/CT has been shown consistently to improve detection of extranodal tumor sites compared to ceCT, with a sensitivity and specificity both >95% for initial staging of NHL and HL. Upstaging of disease may occur in up to 30% of patients using the results of PET/CT compared to conventional CT alone. The authors discuss marginal zone lymphoma (including mucosa-associated lymphoid tissue tumors), which is the third most common histologic subtype behind follicular and diffuse large B-cell. Marginal zone has a particular propensity to involve extranodal sites, most commonly in the stomach, lung, orbit, and parotid gland. PET/CT can identify such sites in >50% of patients with this histology, although some of these tumors have low or very low FDG avidity. The authors also discuss uptake in brown fat and various methods that can be used to reduce his problem. They point out that diffuse uptake in spleen and/or bone marrow is typically the result of hematopoietic stimulation after therapy, whereas tumor involvement is more irregular. They recommend that post-chemotherapy PET/CT not be performed until 4 to 6 weeks following completion of treatment. In the case of radiotherapy, they recommend 8 to 12 weeks. Extranodal involvement in the head/neck region is particularly common in diffuse large B-cell lymphoma, with a variety of sites in addition to Waldeyer ring. CNS involvement is uncommon in lymphoma but should be evaluated when PET is performed. Lung involvement from lymphoma is usually the result of tumor extension from hilar or mediastinal nodal disease. New focal lung uptake in patients showing response to therapy at other tumor sites should be considered infectious in origin. Thymic hyperplasia seen following chemotherapy, which is very often mildly to moderately FDG avid, should not be mistaken for tumor. Lymphomatous involvement of bone marrow is common and can affect therapy significantly. PET/CT can be used to direct bone marrow biopsy and is particularly useful if the initial iliac crest biopsy was negative. Reviewer's Comments: As with all radiographic articles, this has very nice figures to go along with the text. The authors show examples of lymphoma involving many different organs, particularly in the abdomen. (Reviewer-David Bushnell, MD).
OS-EM SPECT Requires More Iterations for Accurate Quantitation
The Impact of Reconstruction Method on the Quantification of DaTSCAN Images. Although iterative ordered subset expectation maximization reconstructions appear to need relatively few iterations to achieve good image quality, quantitative accuracy often requires substantially more iterations than are commonly used for clinical evaluations.
Background: Iterative reconstruction produces better qualitative images than does filtered backprojection, but quantitative accuracy is compromised when the number of iterations is insufficient for convergence. Objective: To investigate the quantification of I-123-FP-CIT (DaTSCAN) brain SPECT studies by comparing iterative and filtered backprojection reconstructions. For iterative reconstruction, accuracy was assessed as a function of the number of iterations. Methods: The striatal compartment of an anthropomorphic brain phantom was filled with I-123 and was imaged on 5 different SPECT systems. Studies were acquired with the striatal-to-background ratio adjusted in the range from 2:1 to 10:1. These studies were reconstructed using an ordered subset expectation maximization (OS-EM) algorithm that included spatial resolution, but without depth dependence, and with standard filtered backprojection (FBP). No corrections were made for scatter or attenuation. Quantitative accuracy of OS-EM reconstructed images was evaluated as a function of different combinations of subsets and iteration numbers and was compared to that of FBP. Results: In cases where the actual striatal-to-background ratio was 5:1 or less, convergence of the measured ratio in the reconstructed images occurred when the equivalent number of iterations (iterations x subset size) was about 100 for all 5 SPECT systems. Above this level, no consistent pattern of convergence was observed, even out to 200 equivalent iterations. In general, measured ratios from OS-EM reconstructions were larger that those found in FBP reconstructed images. This is probably due to the resolution recovery that was included for OS-EM. Conclusions: Measurement errors can be expected in OS-EM reconstructed images if insufficient iterations are used. The authors warn of possible bias in low-count density portions of the image. Reviewer's Comments: This paper is a mixed bag. It makes the very good point that iterative reconstructions do not achieve convergence to an accurate solution without a large number of iterations. However, the study is flawed because of the oversimplified approach to modeling spatial resolution and because of differences that exist in the 5 SPECT systems. It is likely that part of the reason for the slow convergence was related to the inadequacy of using a constant spatial resolution factor that (if the paper is not in error) did not correspond to any of the SPECT systems. The results would be more compelling if either no spatial resolution component was included, or better, the inclusion of an accurate model of spatial resolution with depth dependence. (Reviewer-Mark T. Madsen, MD).
Preop PET Identifies Patients Who Will Benefit Most From CABG
Impact of Preoperative Positron Emission Tomography in Patients With Severely Impaired LV-Function Undergoing
Surgical Revascularization. Patients who are selected for coronary artery bypass grafting using PET viability results have better perioperative and long-term survival than do patients who are not.
Background: PET can be used to evaluate for tissue viability in patients with ischemic cardiomyopathy. Previous studies have shown that viability as determined by PET can predict reversibility of LV dysfunction in response to revascularization. PET viability can also be used to predict improvement in heart failure symptoms and exercise capacity. Revascularization with coronary artery bypass grafting (CABG) is associated with significant perioperative mortality. Objective: To determine whether the use of PET viability in allocating patients to CABG results in better postoperative patient survival. Design: Retrospective study. Participants/Methods: 476 consecutive patients with ischemic cardiomyopathy were referred for CABG. Postoperative survival in patients who were evaluated clinically and angiographically was compared with that of patients who also had supplementary PET viability testing. Cardiomyopathy was defined as left ventricular ejection fraction ≤35%. In patients who underwent PET, resting myocardial perfusion images were obtained using N-13 ammonia followed by metabolic imaging with 18F-FDG. Myocardial perfusion and metabolism images were compared. Criteria for viability were (1) reduced perfusion with preserved or increased FDG uptake (mismatch) or (2) normal perfusion and normal or increased FDG uptake (normal). Nonviability or scar was considered to be present if both perfusion and metabolism were reduced (match). Patients were considered suitable candidates for CABG if they had a normal or mismatch pattern in an area of hypokinetic myocardium supplied by a stenosed or obstructed vessel, and viable myocardium was detected in at least 2 vascular territories. Patients were considered to not be suitable candidates for CABG if at least 40% of myocardium was scarred. Results: Based on the presence of large scar, 26 patients did not undergo CABG, but underwent heart transplant or medical therapy instead. Mean follow-up time was 3.8 years. The PET-CABG group included 152 patients, and the standard care group included 298. There were 2 in-hospital deaths in the PET-CABG group (1.3%) and 30 (10.1%) in the standard care group (P =0.018). The survival rate after 1, 5, and 10 years was 92.0%, 73.3%, and 54.2%, respectively, in the PET-CABG group and 88.9%, 62.2%, and 35.5%, respectively, in the standard care group (P =0.005).
Conclusions:
In patients with ischemic cardiomyopathy, patient selection by preoperative PET viability testing results in better perioperative and long-term survival. Reviewer's Comments: A cut-off of 40% myocardial scar was chosen to exclude patients from CABG because of the risk of perioperative cardiogenic shock in patients with large infarcts. (Reviewer-Shayne Squires, MD).
